Grow your business safely with Resonance Pharma
All the information you need about Resonance Pharma to develop and secure your business in France
R
HOME >
CORPORATES
>
Resonance Pharma >
BALANCE SHEET (
2022-07-06)
THE LIST OF BALANCE SHEET : Resonance Pharma
| Deposit | Confidentiality | closing date | document |
|---|---|---|---|
| 2022-07-06 | Public | 2021-12-31 | Complete |
| 2020-06-15 | Public | 2019-12-31 | Complete |
| 2018-08-21 | Public | 2017-12-31 | Complete |
| Name | Resonance Pharma |
| Siren | 821350436 |
| Closing | 2021-12-31 |
| Registry code | 3302 |
| Registration number | 19909 |
| Management number | 2016B03142 |
| Activity code | 7219Z |
| Closing date n-1 | 2020-12-31 |
| Duration Fiscal year | 12 |
| Duration Fiscal year n-1 | 12 |
| Filing date | 2022-07-06 |
| Modification | 00 Annual accounts entered without anomaly |
| Balance sheet type | C : Complete |
| Currency code | EUR |
| Confidentiality | Public |
| Address | 33600 Pessac |
| 1 - Assets (balance sheet) | Gross amount year N | Amortization year N | Net year N | Net year N-1 |
AT Other tangible assets | 2 297.00 | 1 424.00 | 872.00 | 2 297.00 |
BJ TOTAL (I) | 2 297.00 | 1 424.00 | 872.00 | 2 297.00 |
BZ Other receivables | 163.00 | 163.00 | 163.00 | |
CF Cash and cash equivalents | 20 238.00 | 20 238.00 | 20 238.00 | |
CJ TOTAL (II) | 20 401.00 | 20 401.00 | 20 401.00 | |
CO Grand total (0 to V) | 22 698.00 | 1 424.00 | 21 274.00 | 22 698.00 |
| 2 - Liabilities (balance sheet) | Amount year N | Amount year N-1 | ||
DA Share or individual capital | 6 000.00 | 6 000.00 | 6 000.00 | |
DD Legal reserve (1) | 600.00 | 600.00 | 600.00 | |
DH Retained earnings | 6 237.00 | 6 282.00 | 6 237.00 | |
DI RESULTS FOR THE YEAR (Profit or Loss) | 3 952.00 | -45.00 | 3 952.00 | |
DL TOTAL (I) | 16 788.00 | 12 837.00 | 16 788.00 | |
DV Miscellaneous Loans and Financial Debts (4) | 1 495.00 | 3 645.00 | 1 495.00 | |
DX Trade payables and related accounts | 979.00 | 979.00 | ||
DY Tax and social security liabilities | 2 011.00 | 2 011.00 | ||
EC TOTAL (IV) | 4 485.00 | 3 645.00 | 4 485.00 | |
EE Grand total (I to V) | 21 274.00 | 16 482.00 | 21 274.00 | |
EG Accrued income and payables due within one year | 4 485.00 | 3 645.00 | 4 485.00 | |
EI Including equity loans | 1 495.00 | 1 495.00 | ||
| 3 - Income statement | Amount France year N | Amount Export year N | Total year N | Total year N-1 |
FG Production sold - services | 10 000.00 | 10 000.00 | 10 000.00 | |
FJ Net sales | 10 000.00 | 10 000.00 | 10 000.00 | |
FR Total operating income (I) | 10 000.00 | |||
FU Purchases of raw materials and other supplies | 1 090.00 | |||
FW Other purchases and external expenses | 3 407.00 | |||
FX Taxes, duties, and similar payments | 417.00 | |||
GA Operating Expenses - Depreciation and Amortization | 436.00 | |||
GF Total Operating Expenses (II) | 5 350.00 | |||
GG - OPERATING RESULT (I - II) | 4 650.00 | |||
GW - CURRENT INCOME BEFORE TAX (I - II + III - IV + V - VI) | 4 650.00 | |||
| 4 - Income statement (continued) | Amount year N | Amount year N-1 | ||
HK Income tax | 698.00 | 698.00 | ||
HL TOTAL REVENUE (I + III + V + VII) | 10 000.00 | 6 460.00 | 10 000.00 | |
HM TOTAL EXPENSES (II + IV + VI + VIII + IX + X) | 6 048.00 | 6 505.00 | 6 048.00 | |
HN PROFIT OR LOSS (Total revenue - Total expenses) | 3 952.00 | -45.00 | 3 952.00 | |
all companies in France
Complete and comprehensive database.
